Evidence map›Paper›PMID 38693555›Full record

ArticleJournal of cheminformatics2024

From papers to RDF-based integration of physicochemical data and adverse outcome pathways for nanomaterials.

Jeaphianne P M van Rijn, Marvin Martens, Ammar Ammar, Mihaela Roxana Cimpan, Valerie Fessard, Peter Hoet, Nina Jeliazkova, Sivakumar Murugadoss, Ivana Vinković Vrček, Egon L Willighagen

Abstract read
In one paragraph

Article in Journal of cheminformatics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Jeaphianne P M van RijnDept of Bioinformatics, BiGCaT, NUTRIM, FHML, Maastricht University, Maastricht, The Netherlands.ORCID http://orcid.org/0000-0001-5026-7705
Marvin MartensDept of Bioinformatics, BiGCaT, NUTRIM, FHML, Maastricht University, Maastricht, The Netherlands.ORCID http://orcid.org/0000-0003-2230-0840
Ammar AmmarDept of Bioinformatics, BiGCaT, NUTRIM, FHML, Maastricht University, Maastricht, The Netherlands.ORCID http://orcid.org/0000-0002-8399-8990
Mihaela Roxana CimpanDepartment of Clinical Dentistry, Faculty of Medicine, University of Bergen, Bergen, Norway.
Valerie FessardFougères Laboratory, Anses, French Agency for Food, Environmental and Occupational Health and Safety, Toxicology of Contaminants Unit, Fougères, France.ORCID http://orcid.org/0000-0001-9046-9117
Peter HoetLaboratory of Toxicology, Unit of Environment and Health, Department of Public Health and Primary Care, KU Leuven, Leuven, Belgium.
Nina JeliazkovaIdeaconsult Ltd., Sofia, 1000, Bulgaria.ORCID http://orcid.org/0000-0002-4322-6179
Sivakumar MurugadossLaboratory of Toxicology, Unit of Environment and Health, Department of Public Health and Primary Care, KU Leuven, Leuven, Belgium.
Ivana Vinković VrčekInstitute for Medical Research and Occupational Health, Zagreb, Croatia.ORCID http://orcid.org/0000-0003-1382-5581
Egon L WillighagenDept of Bioinformatics, BiGCaT, NUTRIM, FHML, Maastricht University, Maastricht, The Netherlands. egon.willighagen@maastrichtuniversity.nl.ORCID http://orcid.org/0000-0001-7542-0286

Funding

Horizon 2020 814425Horizon 2020 814572Horizon 2020 862195Norges Forskningsråd 288768
6 · The paper itself

Abstract

Adverse Outcome Pathways (AOPs) have been proposed to facilitate mechanistic understanding of interactions of chemicals/materials with biological systems. Each AOP starts with a molecular initiating event (MIE) and possibly ends with adverse outcome(s) (AOs) via a series of key events (KEs). So far, the interaction of engineered nanomaterials (ENMs) with biomolecules, biomembranes, cells, and biological structures, in general, is not yet fully elucidated. There is also a huge lack of information on which AOPs are ENMs-relevant or -specific, despite numerous published data on toxicological endpoints they trigger, such as oxidative stress and inflammation. We propose to integrate related data and knowledge recently collected. Our approach combines the annotation of nanomaterials and their MIEs with ontology annotation to demonstrate how we can then query AOPs and biological pathway information for these materials. We conclude that a FAIR (Findable, Accessible, Interoperable, Reusable) representation of the ENM-MIE knowledge simplifies integration with other knowledge. SCIENTIFIC CONTRIBUTION: This study introduces a new database linking nanomaterial stressors to the first known MIE or KE. Second, it presents a reproducible workflow to analyze and summarize this knowledge. Third, this work extends the use of semantic web technologies to the field of nanoinformatics and nanosafety.

Indexed as

Adverse outcome pathwaysEngineered nanomaterialsNanosafetyResource description framework

Identifiers

PMID38693555
PMCPMC11064368

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.